American Association for Cancer Research
Browse
00085472can076286-sup-sfig_legends_1-5.pdf (60.7 kB)

Supplementary Figure Legends 1-5 from Targeting AKT Signaling Sensitizes Cancer to Cellular Immunotherapy

Download (60.7 kB)
journal contribution
posted on 2023-03-30, 17:41 authored by Patricia S. Hähnel, Sonja Thaler, Edite Antunes, Christoph Huber, Matthias Theobald, Martin Schuler
Supplementary Figure Legends 1-5 from Targeting AKT Signaling Sensitizes Cancer to Cellular Immunotherapy

History

ARTICLE ABSTRACT

The promise of cancer immunotherapy is long-term disease control with high specificity and low toxicity. However, many cancers fail immune interventions, and secretion of immunosuppressive factors, defective antigen presentation, and expression of death ligands or serpins are regarded as main escape mechanisms. Here, we study whether deregulation of growth and survival factor signaling, which is encountered in most human cancers, provides another level of protection against immunologic tumor eradication. We show in two models that activated cell autonomous protein kinase B (PKB)/AKT signaling mediates resistance against tumor suppression by antigen-specific CTLs in vitro and adoptively transferred cellular immune effectors in vivo. PKB/AKT-dependent immunoresistance of established tumors is reversed by genetic suppression of endogenous Mcl-1, an antiapoptotic member of the Bcl-2 family. Mechanistically, deregulated PKB/AKT stabilizes Mcl-1 expression in a mammalian target of rapamycin (mTOR)–dependent pathway. Treatment with the mTOR inhibitor rapamycin effectively sensitizes established cancers to adoptive immunotherapy in vivo. In conclusion, cancer cell–intrinsic PKB/AKT signaling regulates the susceptibility to immune-mediated cytotoxicity. Combined targeting of signal transduction pathways may be critical for improvement of cancer immunotherapies. [Cancer Res 2008;68(10):3899–906]

Usage metrics

    Cancer Research

    Categories

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC